Maxim Group Initiates Coverage On 180 Life Sciences with Buy Rating, Announces Price Target of $11
Maxim Group analyst Jason McCarthy initiates coverage on 180 Life Sciences (NASDAQ:ATNF) with a Buy rating and announces Price Target of $11.